Methamphetamine
Back to searchMolecule Structure
Scientific Name
Methamphetamine
Description of the Drug
Metamfetamine is a sympathomimetic agent used in the treatment of attention deficit hyperactivity disorder (ADHD) and exogenous obesity.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01577
http://www.drugbank.ca/drugs/DB01577
Brand Name(s)
Not Available
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Rexar Pharmacal, Mayne Pharma Inc, Key Therapeutics Llc, Hikma Pharmaceuticals Usa Inc, Able Laboratories Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Monoamine transporter | PROTEIN FAMILY | INHIBITOR | CHEMBL2363064 |
Clinical Trial(s)
Unichem Links
| Atlas | methamphetamine | ||
| SureChEMBL | SCHEMBL42615 | ||
| PharmGKB | PA450403 | ||
| Human Metabolome Database | HMDB0015517 | ||
| DrugBank | DB01577 | ||
| PubChem: Thomson Pharma | 15194699 | ||
| PubChem | 10836 | ||
| NMRShiftDB | 60021634 | ||
| Nikkaji | J6.362B | ||
| PDBe | B40 | ||
| BindingDB | 50359499 | ||
| EPA CompTox Dashboard | DTXSID8037128 | ||
| DrugCentral | 1732 | ||
| Brenda | 219690 | ||
| rxnorm | DESOXYN | METHAMPHETAMINE | METHAMPHETAMINE HYDROCHLORIDE |
| KEGG Ligand | C07164 | ||
| ChEBI | 6809 | ||
| ZINC | ZINC000006021043 |
